SCHEMBL6388993

SCHEMBL6388993

COC(=O)CCCCC(=O)c1ccc(-c2ccc(C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
CTNNB1 P35222 1/20 0.49
WNT3A P56704 1/20 0.49
HDAC1 Q13547 4/20 0.48
HDAC8 Q9BY41 4/20 0.48
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
GSK3B P49841 1/20 0.44
PDE4B Q07343 1/20 0.44
CSF1R P07333 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B3 P37058 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9077880 0.95 KMT2A (0.55) KMT2ACTNNB1WNT3AHDAC1HDAC8
SCHEMBL25456558 0.93 KMT2A (0.53) KMT2ACTNNB1WNT3AHDAC1HDAC8
SCHEMBL7865396 0.90 KMT2A (0.58) KMT2ACTNNB1WNT3AMMP2MMP9
SCHEMBL10986985 0.87 HDAC1 (0.63) KMT2AHDAC1HDAC8ALDH1A1MAPT
SCHEMBL8535748 0.84 KMT2A (0.63) KMT2ACTNNB1WNT3AALDH1A1POLB
SCHEMBL6138894 0.83 ALDH1A1 (0.50) KMT2AHDAC1HDAC8ALDH1A1NPC1
SCHEMBL6138736 0.83 HAO1 (0.56) HDAC1HDAC8MMP2MMP9MMP8
SCHEMBL9419411 0.82 KMT2A (0.69) KMT2ACTNNB1WNT3AALDH1A1MAPT
SCHEMBL9077833 0.81 HSD17B3 (0.66) HDAC1HDAC8ALDH1A1POLBNPC1
SCHEMBL6138742 0.81 CSF1R (0.43) CTNNB1WNT3AHDAC1HDAC8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119305-A1 Il-6 production inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119305-A1 Il-6 production inhibitors IL6, IL6ST, PADI6 KMT2A 829/4885CTNNB1 1722/4885WNT3A 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.